BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 32384189)

  • 1. Serum metabolomic profiling in patients with Alzheimer disease and amnestic mild cognitive impairment by GC/MS.
    Sun C; Gao M; Wang F; Yun Y; Sun Q; Guo R; Yan C; Sun X; Li Y
    Biomed Chromatogr; 2020 Sep; 34(9):e4875. PubMed ID: 32384189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma metabolite profiles of Alzheimer's disease and mild cognitive impairment.
    Wang G; Zhou Y; Huang FJ; Tang HD; Xu XH; Liu JJ; Wang Y; Deng YL; Ren RJ; Xu W; Ma JF; Zhang YN; Zhao AH; Chen SD; Jia W
    J Proteome Res; 2014 May; 13(5):2649-58. PubMed ID: 24694177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A blood-based, 7-metabolite signature for the early diagnosis of Alzheimer's disease.
    Olazarán J; Gil-de-Gómez L; Rodríguez-Martín A; Valentí-Soler M; Frades-Payo B; Marín-Muñoz J; Antúnez C; Frank-García A; Acedo-Jiménez C; Morlán-Gracia L; Petidier-Torregrossa R; Guisasola MC; Bermejo-Pareja F; Sánchez-Ferro Á; Pérez-Martínez DA; Manzano-Palomo S; Farquhar R; Rábano A; Calero M
    J Alzheimers Dis; 2015; 45(4):1157-73. PubMed ID: 25649659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum metabolomic profiling in patients with systemic lupus erythematosus by GC/MS.
    Yan B; Huang J; Zhang C; Hu X; Gao M; Shi A; Zha W; Shi L; Huang C; Yang L
    Mod Rheumatol; 2016 Nov; 26(6):914-922. PubMed ID: 26915395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma metabolomics in early Alzheimer's disease patients diagnosed with amyloid biomarker.
    Peña-Bautista C; Roca M; Hervás D; Cuevas A; López-Cuevas R; Vento M; Baquero M; García-Blanco A; Cháfer-Pericás C
    J Proteomics; 2019 May; 200():144-152. PubMed ID: 30978462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-Throughput Metabolomics for Discovering Potential Metabolite Biomarkers and Metabolic Mechanism from the APPswe/PS1dE9 Transgenic Model of Alzheimer's Disease.
    Yu J; Kong L; Zhang A; Han Y; Liu Z; Sun H; Liu L; Wang X
    J Proteome Res; 2017 Sep; 16(9):3219-3228. PubMed ID: 28753016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered Gut Microbial Metabolites in Amnestic Mild Cognitive Impairment and Alzheimer's Disease: Signals in Host-Microbe Interplay.
    Wu L; Han Y; Zheng Z; Peng G; Liu P; Yue S; Zhu S; Chen J; Lv H; Shao L; Sheng Y; Wang Y; Li L; Li L; Wang B
    Nutrients; 2021 Jan; 13(1):. PubMed ID: 33466861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolomic profiling of serum in the progression of Alzheimer's disease by capillary electrophoresis-mass spectrometry.
    González-Domínguez R; García A; García-Barrera T; Barbas C; Gómez-Ariza JL
    Electrophoresis; 2014 Dec; 35(23):3321-30. PubMed ID: 25136972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulation of multiple metabolic networks related to brain transmethylation and polyamine pathways in Alzheimer disease: A targeted metabolomic and transcriptomic study.
    Mahajan UV; Varma VR; Griswold ME; Blackshear CT; An Y; Oommen AM; Varma S; Troncoso JC; Pletnikova O; O'Brien R; Hohman TJ; Legido-Quigley C; Thambisetty M
    PLoS Med; 2020 Jan; 17(1):e1003012. PubMed ID: 31978055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer's disease using metabolomics.
    Trushina E; Dutta T; Persson XM; Mielke MM; Petersen RC
    PLoS One; 2013; 8(5):e63644. PubMed ID: 23700429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Community-Based Study Identifying Metabolic Biomarkers of Mild Cognitive Impairment and Alzheimer's Disease Using Artificial Intelligence and Machine Learning.
    Yilmaz A; Ustun I; Ugur Z; Akyol S; Hu WT; Fiandaca MS; Mapstone M; Federoff H; Maddens M; Graham SF
    J Alzheimers Dis; 2020; 78(4):1381-1392. PubMed ID: 33164929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary Metabolomic Profiling in Chronic Hepatitis B Viral Infection Using Gas Chromatography/Mass Spectrometry.
    Dittharot K; Jittorntam P; Wilairat P; Sobhonslidsuk A
    Asian Pac J Cancer Prev; 2018 Mar; 19(3):741-748. PubMed ID: 29582629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-resolution metabolomic profiling of Alzheimer's disease in plasma.
    Niedzwiecki MM; Walker DI; Howell JC; Watts KD; Jones DP; Miller GW; Hu WT
    Ann Clin Transl Neurol; 2020 Jan; 7(1):36-45. PubMed ID: 31828981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiles of subgingival microbiomes and gingival crevicular metabolic signatures in patients with amnestic mild cognitive impairment and Alzheimer's disease.
    Qiu C; Zhou W; Shen H; Wang J; Tang R; Wang T; Xie X; Hong B; Ren R; Wang G; Song Z
    Alzheimers Res Ther; 2024 Feb; 16(1):41. PubMed ID: 38373985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolomic Analysis Using Liquid Chromatography/Mass Spectrometry for Gastric Cancer.
    Liang Q; Wang C; Li B
    Appl Biochem Biotechnol; 2015 Aug; 176(8):2170-84. PubMed ID: 26088916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer's disease: a pilot study.
    Costa AC; Joaquim HPG; Forlenza OV; Gattaz WF; Talib LL
    Eur Arch Psychiatry Clin Neurosci; 2020 Jun; 270(4):483-488. PubMed ID: 31218445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum amino acid metabolic profiles of ankylosing spondylitis by targeted metabolomics analysis.
    Zhou Y; Zhang X; Chen R; Han S; Liu Y; Liu X; Gao M; Yang C; Lu D; Sun B; Chen H
    Clin Rheumatol; 2020 Aug; 39(8):2325-2336. PubMed ID: 32130577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Untargeted metabolomic analysis of human plasma indicates differentially affected polyamine and L-arginine metabolism in mild cognitive impairment subjects converting to Alzheimer's disease.
    Graham SF; Chevallier OP; Elliott CT; Hölscher C; Johnston J; McGuinness B; Kehoe PG; Passmore AP; Green BD
    PLoS One; 2015; 10(3):e0119452. PubMed ID: 25803028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered Expression Profile of Phosphatidylinositols in Erythrocytes of Alzheimer's Disease and Amnestic Mild Cognitive Impairment Patients.
    Chen Y; Lin C; Guo Z; Zhao S; Zhu Y; Huang F; Shui G; Lam SM; Pu J; Yan Y; Liu Z; Zhang B
    J Alzheimers Dis; 2020; 73(2):811-818. PubMed ID: 31868671
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.